Millions of people use injectable drugs like Wegovy to reach a healthier weight. But the weekly injections aren't for everybody — or every wallet.

That's why experimental pills that could achieve similar results are drawing so much attention.

The medicines haven't yet won approval from the Food and Drug Administration, but the first one could get the green light by the end of the year.

"The patient community in the obesity space has … gone without treatment for so long," says Tracy Zvenyach , director of policy strategy and alliances at the nonprofit Obesity Action Coalition . "So new innovations, new treatments to treat this chronic disease — all are welcome. All are exciting." The coalition receives financial support from multiple drugmakers , including Novo Nordisk, Eli Lilly a

See Full Page